Global Biologics Market Research Report 2023

Publisher Name :
Date: 06-Feb-2023
No. of pages: 99
Inquire Before Buying

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA.

The global Biologics market was valued at US$ 104160 million in 2022 and is anticipated to reach US$ 149290 million by 2029, witnessing a CAGR of 5.2% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North America dominated with respect to revenue generation owing to the presence of significant established participants in this region. Moreover, higher demand for the products for treatment of diseases is attributive for larger revenue share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics.

The Biologics market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biologics market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biologics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- Eli Lilly & Company

- Samsung Biologics

- F Hoffman La Roche

- Celltrion

- Addgene

- Amgen

- Abbvie Inc.

- Sanofi

- Pfizer Inc.

- Merck & Co. Inc.

- Novo Nordisk A/S

- Johnson & Johnson Services Inc.

Segment by Type

- Monoclonal Antibodies

- Vaccines

- Recombinant Proteins

- Antisense

- RNAi

Segment by Application

- Infectious Diseases

- Oncology

- Immunology

- Autoimmune Diseases

Production by Region

- North America

- Europe

- China

- Japan

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - China Taiwan

- - Southeast Asia

- - India

- Latin America

- - Mexico

- - Brazil

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Biologics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Production/output, value of Biologics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 4: Consumption of Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: The main points and conclusions of the report.

Global Biologics Market Research Report 2023

Table of Contents
1 Biologics Market Overview
1.1 Product Definition
1.2 Biologics Segment by Type
1.2.1 Global Biologics Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Monoclonal Antibodies
1.2.3 Vaccines
1.2.4 Recombinant Proteins
1.2.5 Antisense
1.2.6 RNAi
1.3 Biologics Segment by Application
1.3.1 Global Biologics Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Infectious Diseases
1.3.3 Oncology
1.3.4 Immunology
1.3.5 Autoimmune Diseases
1.4 Global Market Growth Prospects
1.4.1 Global Biologics Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Biologics Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Biologics Production Estimates and Forecasts (2018-2029)
1.4.4 Global Biologics Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Biologics Production Market Share by Manufacturers (2018-2023)
2.2 Global Biologics Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Biologics, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Biologics Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Biologics, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Biologics, Product Offered and Application
2.8 Global Key Manufacturers of Biologics, Date of Enter into This Industry
2.9 Biologics Market Competitive Situation and Trends
2.9.1 Biologics Market Concentration Rate
2.9.2 Global 5 and 10 Largest Biologics Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Biologics Production by Region
3.1 Global Biologics Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Biologics Production Value by Region (2018-2029)
3.2.1 Global Biologics Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Biologics by Region (2024-2029)
3.3 Global Biologics Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Biologics Production by Region (2018-2029)
3.4.1 Global Biologics Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Biologics by Region (2024-2029)
3.5 Global Biologics Market Price Analysis by Region (2018-2023)
3.6 Global Biologics Production and Value, Year-over-Year Growth
3.6.1 North America Biologics Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Biologics Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Biologics Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Biologics Production Value Estimates and Forecasts (2018-2029)
4 Biologics Consumption by Region
4.1 Global Biologics Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Biologics Consumption by Region (2018-2029)
4.2.1 Global Biologics Consumption by Region (2018-2023)
4.2.2 Global Biologics Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Biologics Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Biologics Consumption by Country (2018-2029)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Biologics Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Biologics Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Biologics Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Biologics Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Biologics Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Biologics Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Biologics Production by Type (2018-2029)
5.1.1 Global Biologics Production by Type (2018-2023)
5.1.2 Global Biologics Production by Type (2024-2029)
5.1.3 Global Biologics Production Market Share by Type (2018-2029)
5.2 Global Biologics Production Value by Type (2018-2029)
5.2.1 Global Biologics Production Value by Type (2018-2023)
5.2.2 Global Biologics Production Value by Type (2024-2029)
5.2.3 Global Biologics Production Value Market Share by Type (2018-2029)
5.3 Global Biologics Price by Type (2018-2029)
6 Segment by Application
6.1 Global Biologics Production by Application (2018-2029)
6.1.1 Global Biologics Production by Application (2018-2023)
6.1.2 Global Biologics Production by Application (2024-2029)
6.1.3 Global Biologics Production Market Share by Application (2018-2029)
6.2 Global Biologics Production Value by Application (2018-2029)
6.2.1 Global Biologics Production Value by Application (2018-2023)
6.2.2 Global Biologics Production Value by Application (2024-2029)
6.2.3 Global Biologics Production Value Market Share by Application (2018-2029)
6.3 Global Biologics Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Eli Lilly & Company
7.1.1 Eli Lilly & Company Biologics Corporation Information
7.1.2 Eli Lilly & Company Biologics Product Portfolio
7.1.3 Eli Lilly & Company Biologics Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Eli Lilly & Company Main Business and Markets Served
7.1.5 Eli Lilly & Company Recent Developments/Updates
7.2 Samsung Biologics
7.2.1 Samsung Biologics Biologics Corporation Information
7.2.2 Samsung Biologics Biologics Product Portfolio
7.2.3 Samsung Biologics Biologics Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Samsung Biologics Main Business and Markets Served
7.2.5 Samsung Biologics Recent Developments/Updates
7.3 F Hoffman La Roche
7.3.1 F Hoffman La Roche Biologics Corporation Information
7.3.2 F Hoffman La Roche Biologics Product Portfolio
7.3.3 F Hoffman La Roche Biologics Production, Value, Price and Gross Margin (2018-2023)
7.3.4 F Hoffman La Roche Main Business and Markets Served
7.3.5 F Hoffman La Roche Recent Developments/Updates
7.4 Celltrion
7.4.1 Celltrion Biologics Corporation Information
7.4.2 Celltrion Biologics Product Portfolio
7.4.3 Celltrion Biologics Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Celltrion Main Business and Markets Served
7.4.5 Celltrion Recent Developments/Updates
7.5 Addgene
7.5.1 Addgene Biologics Corporation Information
7.5.2 Addgene Biologics Product Portfolio
7.5.3 Addgene Biologics Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Addgene Main Business and Markets Served
7.5.5 Addgene Recent Developments/Updates
7.6 Amgen
7.6.1 Amgen Biologics Corporation Information
7.6.2 Amgen Biologics Product Portfolio
7.6.3 Amgen Biologics Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Amgen Main Business and Markets Served
7.6.5 Amgen Recent Developments/Updates
7.7 Abbvie Inc.
7.7.1 Abbvie Inc. Biologics Corporation Information
7.7.2 Abbvie Inc. Biologics Product Portfolio
7.7.3 Abbvie Inc. Biologics Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Abbvie Inc. Main Business and Markets Served
7.7.5 Abbvie Inc. Recent Developments/Updates
7.8 Sanofi
7.8.1 Sanofi Biologics Corporation Information
7.8.2 Sanofi Biologics Product Portfolio
7.8.3 Sanofi Biologics Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Sanofi Main Business and Markets Served
7.7.5 Sanofi Recent Developments/Updates
7.9 Pfizer Inc.
7.9.1 Pfizer Inc. Biologics Corporation Information
7.9.2 Pfizer Inc. Biologics Product Portfolio
7.9.3 Pfizer Inc. Biologics Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Pfizer Inc. Main Business and Markets Served
7.9.5 Pfizer Inc. Recent Developments/Updates
7.10 Merck & Co. Inc.
7.10.1 Merck & Co. Inc. Biologics Corporation Information
7.10.2 Merck & Co. Inc. Biologics Product Portfolio
7.10.3 Merck & Co. Inc. Biologics Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Merck & Co. Inc. Main Business and Markets Served
7.10.5 Merck & Co. Inc. Recent Developments/Updates
7.11 Novo Nordisk A/S
7.11.1 Novo Nordisk A/S Biologics Corporation Information
7.11.2 Novo Nordisk A/S Biologics Product Portfolio
7.11.3 Novo Nordisk A/S Biologics Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Novo Nordisk A/S Main Business and Markets Served
7.11.5 Novo Nordisk A/S Recent Developments/Updates
7.12 Johnson & Johnson Services Inc.
7.12.1 Johnson & Johnson Services Inc. Biologics Corporation Information
7.12.2 Johnson & Johnson Services Inc. Biologics Product Portfolio
7.12.3 Johnson & Johnson Services Inc. Biologics Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Johnson & Johnson Services Inc. Main Business and Markets Served
7.12.5 Johnson & Johnson Services Inc. Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Biologics Industry Chain Analysis
8.2 Biologics Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Biologics Production Mode & Process
8.4 Biologics Sales and Marketing
8.4.1 Biologics Sales Channels
8.4.2 Biologics Distributors
8.5 Biologics Customers
9 Biologics Market Dynamics
9.1 Biologics Industry Trends
9.2 Biologics Market Drivers
9.3 Biologics Market Challenges
9.4 Biologics Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
Table 1. Global Biologics Market Value by Type, (US$ Million) & (2022 VS 2029)
Table 2. Global Biologics Market Value by Application, (US$ Million) & (2022 VS 2029)
Table 3. Global Biologics Production Capacity (K MT) by Manufacturers in 2022
Table 4. Global Biologics Production by Manufacturers (2018-2023) & (K MT)
Table 5. Global Biologics Production Market Share by Manufacturers (2018-2023)
Table 6. Global Biologics Production Value by Manufacturers (2018-2023) & (US$ Million)
Table 7. Global Biologics Production Value Share by Manufacturers (2018-2023)
Table 8. Global Biologics Industry Ranking 2021 VS 2022 VS 2023
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biologics as of 2022)
Table 10. Global Market Biologics Average Price by Manufacturers (USD/MT) & (2018-2023)
Table 11. Manufacturers Biologics Production Sites and Area Served
Table 12. Manufacturers Biologics Product Types
Table 13. Global Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Biologics Production Value by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 16. Global Biologics Production Value (US$ Million) by Region (2018-2023)
Table 17. Global Biologics Production Value Market Share by Region (2018-2023)
Table 18. Global Biologics Production Value (US$ Million) Forecast by Region (2024-2029)
Table 19. Global Biologics Production Value Market Share Forecast by Region (2024-2029)
Table 20. Global Biologics Production Comparison by Region: 2018 VS 2022 VS 2029 (K MT)
Table 21. Global Biologics Production (K MT) by Region (2018-2023)
Table 22. Global Biologics Production Market Share by Region (2018-2023)
Table 23. Global Biologics Production (K MT) Forecast by Region (2024-2029)
Table 24. Global Biologics Production Market Share Forecast by Region (2024-2029)
Table 25. Global Biologics Market Average Price (USD/MT) by Region (2018-2023)
Table 26. Global Biologics Market Average Price (USD/MT) by Region (2024-2029)
Table 27. Global Biologics Consumption Growth Rate by Region: 2018 VS 2022 VS 2029 (K MT)
Table 28. Global Biologics Consumption by Region (2018-2023) & (K MT)
Table 29. Global Biologics Consumption Market Share by Region (2018-2023)
Table 30. Global Biologics Forecasted Consumption by Region (2024-2029) & (K MT)
Table 31. Global Biologics Forecasted Consumption Market Share by Region (2018-2023)
Table 32. North America Biologics Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (K MT)
Table 33. North America Biologics Consumption by Country (2018-2023) & (K MT)
Table 34. North America Biologics Consumption by Country (2024-2029) & (K MT)
Table 35. Europe Biologics Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (K MT)
Table 36. Europe Biologics Consumption by Country (2018-2023) & (K MT)
Table 37. Europe Biologics Consumption by Country (2024-2029) & (K MT)
Table 38. Asia Pacific Biologics Consumption Growth Rate by Region: 2018 VS 2022 VS 2029 (K MT)
Table 39. Asia Pacific Biologics Consumption by Region (2018-2023) & (K MT)
Table 40. Asia Pacific Biologics Consumption by Region (2024-2029) & (K MT)
Table 41. Latin America, Middle East & Africa Biologics Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (K MT)
Table 42. Latin America, Middle East & Africa Biologics Consumption by Country (2018-2023) & (K MT)
Table 43. Latin America, Middle East & Africa Biologics Consumption by Country (2024-2029) & (K MT)
Table 44. Global Biologics Production (K MT) by Type (2018-2023)
Table 45. Global Biologics Production (K MT) by Type (2024-2029)
Table 46. Global Biologics Production Market Share by Type (2018-2023)
Table 47. Global Biologics Production Market Share by Type (2024-2029)
Table 48. Global Biologics Production Value (US$ Million) by Type (2018-2023)
Table 49. Global Biologics Production Value (US$ Million) by Type (2024-2029)
Table 50. Global Biologics Production Value Share by Type (2018-2023)
Table 51. Global Biologics Production Value Share by Type (2024-2029)
Table 52. Global Biologics Price (USD/MT) by Type (2018-2023)
Table 53. Global Biologics Price (USD/MT) by Type (2024-2029)
Table 54. Global Biologics Production (K MT) by Application (2018-2023)
Table 55. Global Biologics Production (K MT) by Application (2024-2029)
Table 56. Global Biologics Production Market Share by Application (2018-2023)
Table 57. Global Biologics Production Market Share by Application (2024-2029)
Table 58. Global Biologics Production Value (US$ Million) by Application (2018-2023)
Table 59. Global Biologics Production Value (US$ Million) by Application (2024-2029)
Table 60. Global Biologics Production Value Share by Application (2018-2023)
Table 61. Global Biologics Production Value Share by Application (2024-2029)
Table 62. Global Biologics Price (USD/MT) by Application (2018-2023)
Table 63. Global Biologics Price (USD/MT) by Application (2024-2029)
Table 64. Eli Lilly & Company Biologics Corporation Information
Table 65. Eli Lilly & Company Specification and Application
Table 66. Eli Lilly & Company Biologics Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 67. Eli Lilly & Company Main Business and Markets Served
Table 68. Eli Lilly & Company Recent Developments/Updates
Table 69. Samsung Biologics Biologics Corporation Information
Table 70. Samsung Biologics Specification and Application
Table 71. Samsung Biologics Biologics Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 72. Samsung Biologics Main Business and Markets Served
Table 73. Samsung Biologics Recent Developments/Updates
Table 74. F Hoffman La Roche Biologics Corporation Information
Table 75. F Hoffman La Roche Specification and Application
Table 76. F Hoffman La Roche Biologics Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 77. F Hoffman La Roche Main Business and Markets Served
Table 78. F Hoffman La Roche Recent Developments/Updates
Table 79. Celltrion Biologics Corporation Information
Table 80. Celltrion Specification and Application
Table 81. Celltrion Biologics Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Celltrion Main Business and Markets Served
Table 83. Celltrion Recent Developments/Updates
Table 84. Addgene Biologics Corporation Information
Table 85. Addgene Specification and Application
Table 86. Addgene Biologics Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Addgene Main Business and Markets Served
Table 88. Addgene Recent Developments/Updates
Table 89. Amgen Biologics Corporation Information
Table 90. Amgen Specification and Application
Table 91. Amgen Biologics Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. Amgen Main Business and Markets Served
Table 93. Amgen Recent Developments/Updates
Table 94. Abbvie Inc. Biologics Corporation Information
Table 95. Abbvie Inc. Specification and Application
Table 96. Abbvie Inc. Biologics Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Abbvie Inc. Main Business and Markets Served
Table 98. Abbvie Inc. Recent Developments/Updates
Table 99. Sanofi Biologics Corporation Information
Table 100. Sanofi Specification and Application
Table 101. Sanofi Biologics Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. Sanofi Main Business and Markets Served
Table 103. Sanofi Recent Developments/Updates
Table 104. Pfizer Inc. Biologics Corporation Information
Table 105. Pfizer Inc. Specification and Application
Table 106. Pfizer Inc. Biologics Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 107. Pfizer Inc. Main Business and Markets Served
Table 108. Pfizer Inc. Recent Developments/Updates
Table 109. Merck & Co. Inc. Biologics Corporation Information
Table 110. Merck & Co. Inc. Specification and Application
Table 111. Merck & Co. Inc. Biologics Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 112. Merck & Co. Inc. Main Business and Markets Served
Table 113. Merck & Co. Inc. Recent Developments/Updates
Table 114. Novo Nordisk A/S Biologics Corporation Information
Table 115. Novo Nordisk A/S Specification and Application
Table 116. Novo Nordisk A/S Biologics Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 117. Novo Nordisk A/S Main Business and Markets Served
Table 118. Novo Nordisk A/S Recent Developments/Updates
Table 119. Johnson & Johnson Services Inc. Biologics Corporation Information
Table 120. Johnson & Johnson Services Inc. Specification and Application
Table 121. Johnson & Johnson Services Inc. Biologics Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 122. Johnson & Johnson Services Inc. Main Business and Markets Served
Table 123. Johnson & Johnson Services Inc. Recent Developments/Updates
Table 124. Key Raw Materials Lists
Table 125. Raw Materials Key Suppliers Lists
Table 126. Biologics Distributors List
Table 127. Biologics Customers List
Table 128. Biologics Market Trends
Table 129. Biologics Market Drivers
Table 130. Biologics Market Challenges
Table 131. Biologics Market Restraints
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biologics
Figure 2. Global Biologics Market Value by Type, (US$ Million) & (2022 VS 2029)
Figure 3. Global Biologics Market Share by Type: 2022 VS 2029
Figure 4. Monoclonal Antibodies Product Picture
Figure 5. Vaccines Product Picture
Figure 6. Recombinant Proteins Product Picture
Figure 7. Antisense Product Picture
Figure 8. RNAi Product Picture
Figure 9. Global Biologics Market Value by Application, (US$ Million) & (2022 VS 2029)
Figure 10. Global Biologics Market Share by Application: 2022 VS 2029
Figure 11. Infectious Diseases
Figure 12. Oncology
Figure 13. Immunology
Figure 14. Autoimmune Diseases
Figure 15. Global Biologics Production Value (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Biologics Production Value (US$ Million) & (2018-2029)
Figure 17. Global Biologics Production Capacity (K MT) & (2018-2029)
Figure 18. Global Biologics Production (K MT) & (2018-2029)
Figure 19. Global Biologics Average Price (USD/MT) & (2018-2029)
Figure 20. Biologics Report Years Considered
Figure 21. Biologics Production Share by Manufacturers in 2022
Figure 22. Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 23. The Global 5 and 10 Largest Players: Market Share by Biologics Revenue in 2022
Figure 24. Global Biologics Production Value by Region: 2018 VS 2022 VS 2029 (US$ Million)
Figure 25. Global Biologics Production Value Market Share by Region: 2018 VS 2022 VS 2029
Figure 26. Global Biologics Production Comparison by Region: 2018 VS 2022 VS 2029 (K MT)
Figure 27. Global Biologics Production Market Share by Region: 2018 VS 2022 VS 2029
Figure 28. North America Biologics Production Value (US$ Million) Growth Rate (2018-2029)
Figure 29. Europe Biologics Production Value (US$ Million) Growth Rate (2018-2029)
Figure 30. China Biologics Production Value (US$ Million) Growth Rate (2018-2029)
Figure 31. Japan Biologics Production Value (US$ Million) Growth Rate (2018-2029)
Figure 32. Global Biologics Consumption by Region: 2018 VS 2022 VS 2029 (K MT)
Figure 33. Global Biologics Consumption Market Share by Region: 2018 VS 2022 VS 2029
Figure 34. North America Biologics Consumption and Growth Rate (2018-2023) & (K MT)
Figure 35. North America Biologics Consumption Market Share by Country (2018-2029)
Figure 36. Canada Biologics Consumption and Growth Rate (2018-2023) & (K MT)
Figure 37. U.S. Biologics Consumption and Growth Rate (2018-2023) & (K MT)
Figure 38. Europe Biologics Consumption and Growth Rate (2018-2023) & (K MT)
Figure 39. Europe Biologics Consumption Market Share by Country (2018-2029)
Figure 40. Germany Biologics Consumption and Growth Rate (2018-2023) & (K MT)
Figure 41. France Biologics Consumption and Growth Rate (2018-2023) & (K MT)
Figure 42. U.K. Biologics Consumption and Growth Rate (2018-2023) & (K MT)
Figure 43. Italy Biologics Consumption and Growth Rate (2018-2023) & (K MT)
Figure 44. Russia Biologics Consumption and Growth Rate (2018-2023) & (K MT)
Figure 45. Asia Pacific Biologics Consumption and Growth Rate (2018-2023) & (K MT)
Figure 46. Asia Pacific Biologics Consumption Market Share by Regions (2018-2029)
Figure 47. China Biologics Consumption and Growth Rate (2018-2023) & (K MT)
Figure 48. Japan Biologics Consumption and Growth Rate (2018-2023) & (K MT)
Figure 49. South Korea Biologics Consumption and Growth Rate (2018-2023) & (K MT)
Figure 50. China Taiwan Biologics Consumption and Growth Rate (2018-2023) & (K MT)
Figure 51. Southeast Asia Biologics Consumption and Growth Rate (2018-2023) & (K MT)
Figure 52. India Biologics Consumption and Growth Rate (2018-2023) & (K MT)
Figure 53. Latin America, Middle East & Africa Biologics Consumption and Growth Rate (2018-2023) & (K MT)
Figure 54. Latin America, Middle East & Africa Biologics Consumption Market Share by Country (2018-2029)
Figure 55. Mexico Biologics Consumption and Growth Rate (2018-2023) & (K MT)
Figure 56. Brazil Biologics Consumption and Growth Rate (2018-2023) & (K MT)
Figure 57. Turkey Biologics Consumption and Growth Rate (2018-2023) & (K MT)
Figure 58. GCC Countries Biologics Consumption and Growth Rate (2018-2023) & (K MT)
Figure 59. Global Production Market Share of Biologics by Type (2018-2029)
Figure 60. Global Production Value Market Share of Biologics by Type (2018-2029)
Figure 61. Global Biologics Price (USD/MT) by Type (2018-2029)
Figure 62. Global Production Market Share of Biologics by Application (2018-2029)
Figure 63. Global Production Value Market Share of Biologics by Application (2018-2029)
Figure 64. Global Biologics Price (USD/MT) by Application (2018-2029)
Figure 65. Biologics Value Chain
Figure 66. Biologics Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
  • Global Nucleotide Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 132
    Nucleotides are organic molecules consisting of a nucleoside and a phosphate. They serve as monomeric units of the nucleic acid polymers deoxyribonucleic acid and ribonucleic acid, both of which are essential biomolecules within all life-forms on Earth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This wa......
  • Global Nucleotide Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 165
    Nucleotides are organic molecules consisting of a nucleoside and a phosphate. They serve as monomeric units of the nucleic acid polymers deoxyribonucleic acid and ribonucleic acid, both of which are essential biomolecules within all life-forms on Earth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This wa......
  • Global Bioburden Testing Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 120
    Report Overview: The Global Bioburden Testing Market Size was estimated at USD 898.90 million in 2022 and is projected to reach USD 1443.44 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Bioburden Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market dri......
  • Global qPCR Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Nov-2023        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global qPCR market: According to our latest research, the global qPCR market looks promising in the next 5 years. As of 2022, the global qPCR market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global qPCR market, with a systematical description of the status ......
  • Global Interferon Market Research Report 2023, Forecast to 2028
    Published: 01-Nov-2023        Price: US 2680 Onwards        Pages: 131
    Interferons are proteins that are part of your natural defenses. They tell your immune system that germs or cancer cells are in your body. And they trigger killer immune cells to fight those invaders. Interferons got their name because they "interfere" with viruses and keep them from multiplying. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Global Interferon Professional Survey Report 2023, Forecast to 2028
    Published: 01-Nov-2023        Price: US 3280 Onwards        Pages: 107
    Interferons are proteins that are part of your natural defenses. They tell your immune system that germs or cancer cells are in your body. And they trigger killer immune cells to fight those invaders. Interferons got their name because they "interfere" with viruses and keep them from multiplying. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Global Biologics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Oct-2023        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Biologics market: According to our latest research, the global Biologics market looks promising in the next 5 years. As of 2022, the global Biologics market was estimated at USD 251622.83 million, and it's anticipated to reach USD 363588.32 million in 2028, with a CAGR of 6.33% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Biologics market, with a sys......
  • Global Nucleotide Market Insights, Forecast to 2029
    Published: 25-Sep-2023        Price: US 4900 Onwards        Pages: 89
    Nucleotides are small organic molecules composed of purine bases or pyrimidine bases, pentoses and phosphoric acid. They are the structural units of nucleic acids, and their derivatives have a variety of biological functions. It can be used in the fields of food, pharmaceuticals and feed additive. The global Nucleotide market is projected to grow from US$ 511.1 million in 2023 to US$ 492.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of -0.6% during the forecast period. ......
  • 2023-2031 Report on Global Nucleotide Market by Player, Region, Type, Application and Sales Channel
    Published: 04-Sep-2023        Price: US 2500 Onwards        Pages: 89
    This report studies the Nucleotide market, covering market size for segment by type (Food Grade Nucleotide, Lab Grade Nucleotide, etc.), by application (Pharmaceuticals, Food & Beverage Additives, etc.), by sales channel (Direct Channel, Distribution Channel), by player (AJINOMOTO, CJ, DAESANG, Meihua Group, Star Lake Bioscience, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of g......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs